StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

Addex Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Addex Therapeutics's enterprise value was -$873.54K on Nov 11, 2026, against -$2.71M a year earlier. Over the last 5 years it ranged from -$21.76M to -$858.87K, with a median of -$4.23M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$873.54K–
2025Dec 31, 2025-$2.75M–
2024Dec 31, 2024-$4.14M–
2023Dec 29, 2023-$8.45M–
2022Dec 30, 2022-$9.47M–
2021Dec 31, 2021-$19.97M–
2020Dec 31, 2020-$34.68M–

More Addex Therapeutics figures

See a number that looks wrong?